FindMyRecallSubscribe
Class II: temporary or reversible health riskOngoing

Apollo Care Succinylcholine Cl Injection Recall

Succinylcholine Cl Injection, 100 mg per 5 mL (20 mg/mL), Single-Use Syringe, Rx only,…

Apollo Care, LLC · Columbia, MO

Risk level
Class II
Reported by FDA
May 24, 2023
Recall ID
D-0633-2023
Check your lot numberHow we source this data

Summary

Apollo Care recalled Succinylcholine Cl Injection starting May 2, 2023. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0633-2023 on May 24, 2023. Reason: Lack of Assurance of Sterility. Status: Ongoing.

Why it was recalled

Lack of Assurance of Sterility

Product description

Succinylcholine Cl Injection, 100 mg per 5 mL (20 mg/mL), Single-Use Syringe, Rx only, Apollo Care, LLC, 3801 Mojave Ct., Suite 101, Columbia, MO 65202. NDC 71170-020-05

Lot numbers, UPCs & expiration codes

Lot #: AC-016607, Exp. Date 05/09/2023

Where it was sold

Missouri only

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0633-2023
Classification
Class II
Status
Ongoing
Recall initiated
May 2, 2023
FDA report date
May 24, 2023
Quantity
90 syringes
Recall type
Voluntary: Firm initiated
Recalling firm
Apollo Care, LLC

Original FDA data

Every field from FDA enforcement report D-0633-2023, exactly as published.

Show all FDA fields
City
Columbia
State
MO
Status
Ongoing
Country
United States
Event ID
92348
Address
3801 Mojave Ct Ste 101
Code information
Lot #: AC-016607, Exp. Date 05/09/2023
Postal code
65202-4042
Report date
May 24, 2023
Product type
Drugs
Recall number
D-0633-2023
Classification
Class II
Recalling firm
Apollo Care, LLC
Product quantity
90 syringes
Reason for recall
Lack of Assurance of Sterility
Voluntary / mandated
Voluntary: Firm initiated
Product description
Succinylcholine Cl Injection, 100 mg per 5 mL (20 mg/mL), Single-Use Syringe, Rx only, Apollo Care, LLC, 3801 Mojave Ct., Suite 101, Columbia, MO 65202. NDC 71170-020-05
Distribution pattern
Missouri only
Recall initiation date
May 2, 2023
Initial firm notification
Letter
Center classification date
May 18, 2023

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0633-2023, published May 24, 2023. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls